Published in Blood Weekly, January 27th, 2000
Researchers found that clot-busting medication called TPA (tissue plasminogen activator) was given safely and resulted in good outcomes for patients at community and rural hospitals that created and followed a stroke care protocol. According to researchers, lack of a stroke treatment protocol is one major reason the clot-buster is not given more often in small hospitals.
TPA is the only US Food...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.